Draig Therapeutics
Developing transformative, best-in-class neuropsychiatric therapies
$65MSeries B
Role not disclosedJL
Jefferson Life Sciences
Activity from announced rounds
Activity in this selectionnrw-venture-f5757e51
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $118.5M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionFesariusTherapeutics
Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery
$20MSeries A
Role not disclosedJuvena Therapeutics
Develops regenerative biologics to restore tissue function
$33.5MSeries B
Role not disclosed